No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Established in Indore, India in 1967, Alpa Laboratories Limited focuses on the manufacturing, marketing, and distribution of finished pharmaceutical products, both domestically within India and for export. The company offers a wide array of human-grade medications, encompassing ethical, generic, and over-the-counter varieties, available in diverse forms such as injections, tablets, capsules, eye and ear drops, ointments, creams, and gels. Furthermore, it supplies veterinary pharmaceuticals, including boluses, injections, and intra-mammary infusions. Its extensive product range addresses numerous therapeutic categories, including anti-infectives (covering antibacterials, antibiotics, antifungals, antiprotozoals, and antivirals), pain relievers, anti-inflammatory drugs, cold and cough remedies, cardiovascular treatments, anti-diabetic agents, nutritional supplements, psychotropic medicines, and specialized preparations for skin, ear, and eye care. Alpa Laboratories distributes its goods through a robust network comprising distributors, retail pharmacies, and hospitals. The company also extends its reach internationally, exporting its products to various regions across South and Central America, Africa, Asia, and the CIS countries.
www.alpalabs.inNo one on the platform currently holds ALPA.NS.
No tracked institution reports a position in ALPA.NS as of their last filing.
No one on the platform has traded ALPA.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ALPA.NSAlpa Laboratories Limited | $60.70 | +0.51% | $1.3B | — |
| AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited | $96.50 | -2.35% | $2.7B | — |
| AASHKA.BOAashka Hospitals Limited | $83.28 | -2.00% | $1.9B | — |
| ACHYUT.BOAchyut Healthcare Ltd. | $6.85 | +0.44% | $1.7B | — |
| BALPHARMA.BOBal Pharma Limited | $100.95 | -5.97% | $1.6B | — |
| BALPHARMA.NSBal Pharma Limited | $101.99 | -5.07% | $1.6B | — |
| CORALAB.BOCoral Laboratories Limited | $567.20 | +0.29% | $2.0B | — |
Source: Financial Modeling Prep · peers by sector/industry